UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5226
CALL
Garmin
GRMN
$55B
| $1.69M | ﹤0.01% |
7,100
+5,600
| +373% | +$1.36M |
2023 Q1
13 quarters
|
|
5227
Columbia Seligman Premium Technology Growth Fund
STK
$848M
| $1.68M | ﹤0.01% |
31,230
-1,988
| -6% | -$98.8K |
2014 Q4
46 quarters
|
|
5228
Myriad Genetics
MYGN
$567M
| $1.68M | ﹤0.01% |
294,346
-408,821
| -58% | -$1.86M |
2014 Q4
46 quarters
|
|
5229
CALL
Huntington Ingalls Industries
HII
$11.4B
| $1.68M | ﹤0.01% |
+6,000
| New | +$2M |
2026 Q2
0 quarters
|
|
5230
Benitec Biopharma
BNTC
$333M
| $1.68M | ﹤0.01% |
125,431
+9,612
| +8% | +$114K |
2020 Q2
24 quarters
|
|
5231
Miller Industries
MLR
$524M
| $1.68M | ﹤0.01% |
32,792
+25,010
| +321% | +$1.2M |
2014 Q4
46 quarters
|
|
5232
BlackRock Enhanced Global Dividend Trust
BOE
$623M
| $1.67M | ﹤0.01% |
138,378
+4,921
| +4% | +$57.9K |
2014 Q4
46 quarters
|
|
5233
Direxion Daily S&P Oil & Gas Exp. & Prod. Bear 2X ETF
DRIP
$186M
| $1.67M | ﹤0.01% |
31,240
+30,672
| +5,400% | +$1.45M |
2025 Q4
2 quarters
|
|
5234
Invesco QQQ Hedged Advantage ETF
QQHG
$12.7M
| $1.67M | ﹤0.01% |
25,000
+24,887
| +22,024% | +$1.6M |
2026 Q1
1 quarter
|
|
5235
Woori Financial
WF
$16.9B
| $1.67M | ﹤0.01% |
29,111
+23,142
| +388% | +$1.5M |
2014 Q4
46 quarters
|
|
5236
Midland States Bancorp
MSBI
$660M
| $1.67M | ﹤0.01% |
53,637
-23,877
| -31% | -$643K |
2016 Q2
40 quarters
|
|
5237
FirstSun Capital Bancorp
FSUN
$1.77B
| $1.67M | ﹤0.01% |
43,024
-1,807
| -4% | -$66.2K |
2024 Q3
7 quarters
|
|
5238
National Presto Industries
NPK
$1.02B
| $1.67M | ﹤0.01% |
13,341
-2,376
| -15% | -$322K |
2014 Q4
46 quarters
|
|
5239
Village Super Market
VLGEA
$610M
| $1.67M | ﹤0.01% |
39,484
+18,172
| +85% | +$781K |
2014 Q4
46 quarters
|
|
5240
PUT
Zillow
Z
$6.66B
| $1.66M | ﹤0.01% |
52,800
-180,600
| -77% | -$6.94M |
2020 Q3
23 quarters
|
|
5241
Invesco Municipal Income Opportunities Trust
OIA
$281M
| $1.66M | ﹤0.01% |
267,645
-2,977
| -1% | -$18.2K |
2014 Q4
46 quarters
|
|
5242
AudioCodes
AUDC
$183M
| $1.66M | ﹤0.01% |
171,616
+36,051
| +27% | +$329K |
2014 Q4
46 quarters
|
|
5243
US Gold Corp
USAU
$187M
| $1.66M | ﹤0.01% |
108,145
-22,837
| -17% | -$361K |
2018 Q3
31 quarters
|
|
5244
Boise Cascade
BCC
$2.44B
| $1.65M | ﹤0.01% |
21,290
-34,752
| -62% | -$2.58M |
2014 Q4
46 quarters
|
|
5245
Ecovyst
ECVT
$1.15B
| $1.65M | ﹤0.01% |
132,509
-300,956
| -69% | -$4.08M |
2021 Q4
18 quarters
|
|
5246
Lexeo Therapeutics
LXEO
$237M
| $1.65M | ﹤0.01% |
354,044
+32,307
| +10% | +$175K |
2024 Q1
9 quarters
|
|
5247
HomeTrust Bancshares
HTB
$743M
| $1.65M | ﹤0.01% |
33,033
-9,657
| -23% | -$447K |
2022 Q4
14 quarters
|
|
5248
Bel Fuse Inc Class A
BELFA
$2.37B
| $1.65M | ﹤0.01% |
5,658
-1,519
| -21% | -$369K |
2023 Q1
13 quarters
|
|
5249
Lexicon Pharmaceuticals
LXRX
$792M
| $1.64M | ﹤0.01% |
684,713
-1,798,469
| -72% | -$3.5M |
2014 Q4
46 quarters
|
|
5250
WisdomTree US Value Fund
WTV
$3.3B
| $1.64M | ﹤0.01% |
+16,150
| New | +$1.61M |
2026 Q2
0 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.